Drug
tocilizumab-aazg
Marketed as TYENNE.
Generic name
tocilizumab-aazg
Brand names
TYENNE
First FDA approval
2025-03-14
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761449 | TYENNE | 2025-03-14 | FRESENIUS KABI USA |
Manufacturers
FRESENIUS KABI USA
Frequently asked questions
When was tocilizumab-aazg FDA approved?
Earliest FDA approval on record: 2025-03-14.
What brand names are sold as tocilizumab-aazg?
TYENNE.
Sources
Appeal a tocilizumab-aazg denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com